ISR was recently reported as being protective, at least initially, in models of mitochondrial cardiomyopathy, including CHCHD10 mutations (Shammas et al, 2022) and cytochrome c oxidase deficiency (Ahola et al, 2022). The gene discussed is CHCHD10; the disease is hyperinsulinemic hypoglycemia, familial, 4.